Enhabit (EHAB) Competitors $8.06 -0.13 (-1.64%) Closing price 03:59 PM EasternExtended Trading$8.06 +0.01 (+0.11%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. AVAH, VRDN, TDOC, AHCO, OMDA, GRAL, PNTG, FTRE, FLGT, and CDNAShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), AdaptHealth (AHCO), Omada Health (OMDA), GRAIL (GRAL), The Pennant Group (PNTG), Fortrea (FTRE), Fulgent Genetics (FLGT), and CareDx (CDNA). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors Aveanna Healthcare Viridian Therapeutics Teladoc Health AdaptHealth Omada Health GRAIL The Pennant Group Fortrea Fulgent Genetics CareDx Enhabit (NYSE:EHAB) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Is EHAB or AVAH more profitable? Aveanna Healthcare has a net margin of 0.85% compared to Enhabit's net margin of -12.84%. Enhabit's return on equity of 2.72% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-12.84% 2.72% 1.25% Aveanna Healthcare 0.85%-54.56%3.17% Does the media favor EHAB or AVAH? In the previous week, Aveanna Healthcare had 13 more articles in the media than Enhabit. MarketBeat recorded 13 mentions for Aveanna Healthcare and 0 mentions for Enhabit. Aveanna Healthcare's average media sentiment score of 0.76 beat Enhabit's score of 0.00 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Overall Sentiment Enhabit Neutral Aveanna Healthcare Positive Which has more volatility & risk, EHAB or AVAH? Enhabit has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Which has stronger earnings & valuation, EHAB or AVAH? Aveanna Healthcare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.03B0.39-$156.20M-$2.67-3.02Aveanna Healthcare$2.02B0.77-$10.93M$0.0892.88 Do institutionals and insiders have more ownership in EHAB or AVAH? 88.0% of Aveanna Healthcare shares are held by institutional investors. 3.4% of Enhabit shares are held by company insiders. Comparatively, 7.0% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer EHAB or AVAH? Enhabit currently has a consensus target price of $8.67, suggesting a potential upside of 7.58%. Aveanna Healthcare has a consensus target price of $7.50, suggesting a potential upside of 0.94%. Given Enhabit's higher possible upside, research analysts clearly believe Enhabit is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Aveanna Healthcare 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SummaryAveanna Healthcare beats Enhabit on 14 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$408.36M$7.69B$5.76B$21.09BDividend YieldN/A2.69%4.40%3.55%P/E Ratio-3.0274.9130.1928.89Price / Sales0.3948.35473.6453.03Price / Cash2.0025.5525.7818.23Price / Book0.747.679.424.69Net Income-$156.20M$242.04M$3.27B$995.89M7 Day Performance1.65%-1.13%2.05%1.90%1 Month Performance19.44%-0.78%3.58%1.72%1 Year Performance-1.88%7.88%30.09%10.19% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit1.2028 of 5 stars$8.06-1.6%$8.67+7.6%-0.5%$408.36M$1.03B-3.0210,700AVAHAveanna Healthcare2.0441 of 5 stars$7.58+7.7%$7.50-1.0%+33.4%$1.58B$2.02B94.7533,500High Trading VolumeVRDNViridian Therapeutics1.7336 of 5 stars$17.43-3.8%$37.00+112.3%+27.8%$1.44B$300K-4.6050News CoverageAnalyst ForecastTDOCTeladoc Health3.0625 of 5 stars$7.47-0.3%$9.76+30.8%+3.4%$1.32B$2.57B-6.275,500AHCOAdaptHealth4.2638 of 5 stars$9.43+0.5%$13.40+42.1%-8.0%$1.28B$3.24B17.4610,500Positive NewsOMDAOmada HealthN/A$20.47-2.1%$24.57+20.0%N/A$1.18BN/A0.00849Positive NewsGRALGRAIL1.1548 of 5 stars$31.60-3.7%$31.50-0.3%+122.2%$1.14B$125.60M-2.411,360PNTGThe Pennant Group3.809 of 5 stars$25.20+0.4%$33.40+32.5%-28.0%$868.32M$695.24M32.217,000FTREFortrea4.064 of 5 stars$7.94+0.2%$13.30+67.6%-62.1%$716.68M$2.73B-0.6915,500FLGTFulgent Genetics3.6664 of 5 stars$21.55+0.1%$25.33+17.6%-8.5%$659.34M$283.47M-12.981,313Positive NewsCDNACareDx4.204 of 5 stars$11.58-2.3%$27.67+138.9%-58.9%$616.90M$340.83M11.36740 Related Companies and Tools Related Companies AVAH Competitors VRDN Competitors TDOC Competitors AHCO Competitors OMDA Competitors GRAL Competitors PNTG Competitors FTRE Competitors FLGT Competitors CDNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access